TP53 and ovarian cancer: As mentioned earlier, the connection between MAPK/ERK and FOXM1 in ovarian cancer has only been demonstrated in EOC cell lines with wild-type p53, and it has been suggested that the MAPK/ERK pathway may not interact with FOXM1 in mutant p53 settings [206].